Miranda van Amersfoort

1.1k total citations
14 papers, 832 citations indexed

About

Miranda van Amersfoort is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Miranda van Amersfoort has authored 14 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Miranda van Amersfoort's work include Cancer Cells and Metastasis (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Miranda van Amersfoort is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Miranda van Amersfoort collaborates with scholars based in Netherlands, United States and United Kingdom. Miranda van Amersfoort's co-authors include Patrick W.B. Derksen, Emile E. Voest, Jeanine M.L. Roodhart, Laura G.M. Daenen, Joost S.P. Vermaat, Laurien H. Ulfman, P. J. van Diest, Wijnand Roessingh, Eva J. Vlug and Jos Jonkers and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Cell.

In The Last Decade

Miranda van Amersfoort

14 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda van Amersfoort Netherlands 11 483 389 242 121 84 14 832
Maria F. Camargo United States 12 586 1.2× 365 0.9× 212 0.9× 139 1.1× 175 2.1× 18 966
Tuyen T. Dang United States 11 564 1.2× 264 0.7× 366 1.5× 141 1.2× 68 0.8× 16 859
Weili Fu United States 11 272 0.6× 327 0.8× 207 0.9× 128 1.1× 86 1.0× 14 754
Karina J. Yoon United States 18 777 1.6× 409 1.1× 168 0.7× 63 0.5× 128 1.5× 48 1.1k
Yin Xu United States 11 600 1.2× 230 0.6× 173 0.7× 169 1.4× 82 1.0× 15 858
Steven T. Sizemore United States 17 584 1.2× 300 0.8× 186 0.8× 91 0.8× 76 0.9× 33 840
Jane D. Holland Germany 10 879 1.8× 569 1.5× 244 1.0× 100 0.8× 160 1.9× 11 1.3k
Junhye Kwon South Korea 18 594 1.2× 274 0.7× 205 0.8× 99 0.8× 47 0.6× 31 854
Barbara Tanno Italy 19 737 1.5× 423 1.1× 268 1.1× 61 0.5× 62 0.7× 45 1.1k
Abhijeet Deshmukh Australia 11 441 0.9× 328 0.8× 281 1.2× 56 0.5× 61 0.7× 11 713

Countries citing papers authored by Miranda van Amersfoort

Since Specialization
Citations

This map shows the geographic impact of Miranda van Amersfoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda van Amersfoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda van Amersfoort more than expected).

Fields of papers citing papers by Miranda van Amersfoort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda van Amersfoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda van Amersfoort. The network helps show where Miranda van Amersfoort may publish in the future.

Co-authorship network of co-authors of Miranda van Amersfoort

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda van Amersfoort. A scholar is included among the top collaborators of Miranda van Amersfoort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda van Amersfoort. Miranda van Amersfoort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Velden, Lieke M. van der, Miranda van Amersfoort, Anneloes Mensinga, et al.. (2022). Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis. Frontiers in Endocrinology. 13. 926210–926210. 10 indexed citations
2.
Hornsveld, Marten, Lydia M.M. Smits, Maaike Meerlo, et al.. (2018). FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression. Cancer Research. 78(9). 2356–2369. 60 indexed citations
3.
Gómez-Cuadrado, Laura, Milou Tenhagen, Adam Byron, et al.. (2018). E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer. Scientific Reports. 8(1). 15454–15454. 42 indexed citations
4.
Amersfoort, Miranda van, Tanja Eisemann, Eva J. Vlug, et al.. (2018). αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer. The Journal of Pathology. 245(4). 456–467. 30 indexed citations
5.
Diest, P. J. van, Miranda van Amersfoort, Eva J. Vlug, et al.. (2017). Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice. Oncotarget. 8(37). 60750–60763. 10 indexed citations
6.
Hornsveld, Marten, Milou Tenhagen, Alida M.M. Smits, et al.. (2016). Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer. Cell Death and Differentiation. 23(9). 1483–1492. 43 indexed citations
7.
Bouchet, Benjamin Pierre, Ivar Noordstra, Miranda van Amersfoort, et al.. (2016). Mesenchymal Cell Invasion Requires Cooperative Regulation of Persistent Microtubule Growth by SLAIN2 and CLASP1. Developmental Cell. 39(6). 708–723. 56 indexed citations
8.
Schackmann, Ron C.J., Sjoerd Klarenbeek, Eva J. Vlug, et al.. (2013). Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling. Cancer Research. 73(15). 4937–4949. 48 indexed citations
9.
Roodhart, Jeanine M.L., Huanhuan He, Laura G.M. Daenen, et al.. (2013). Notch1 regulates angio-supportive bone marrow–derived cells in mice: relevance to chemoresistance. Blood. 122(1). 143–153. 22 indexed citations
10.
Roodhart, Jeanine M.L., Laura G.M. Daenen, Chad L. Barber, et al.. (2012). Abstract 1022: Notch regulates the egression of angio-supportive bone marrow-derived cells after chemotherapy. Cancer Research. 72(8_Supplement). 1022–1022. 1 indexed citations
11.
Daenen, Laura G.M., Jeanine M.L. Roodhart, Miranda van Amersfoort, et al.. (2011). Chemotherapy Enhances Metastasis Formation via VEGFR-1–Expressing Endothelial Cells. Cancer Research. 71(22). 6976–6985. 142 indexed citations
12.
Oerlemans, Chris, J. Frank W. Nijsen, Miranda van Amersfoort, et al.. (2011). A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release. European Journal of Pharmaceutics and Biopharmaceutics. 77(3). 458–464. 7 indexed citations
13.
Roodhart, Jeanine M.L., Laura G.M. Daenen, Edwin C.A. Stigter, et al.. (2011). Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids. Cancer Cell. 20(3). 370–383. 254 indexed citations
14.
Schackmann, Ron C.J., Miranda van Amersfoort, Judith H.I. Haarhuis, et al.. (2011). Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. Journal of Clinical Investigation. 121(8). 3176–3188. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026